Lancet Child & Adolescent Health

Papers
(The H4-Index of Lancet Child & Adolescent Health is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review1289
Mental health effects of school closures during COVID-191065
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study897
Delayed access or provision of care in Italy resulting from fear of COVID-19890
The effects of social deprivation on adolescent development and mental health587
Mental health considerations for children quarantined because of COVID-19518
Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals391
Protecting the psychological health of children through effective communication about COVID-19351
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study327
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study299
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2281
Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study255
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study225
Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study216
Promoting healthy movement behaviours among children during the COVID-19 pandemic212
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process204
Children and young people remain at low risk of COVID-19 mortality199
SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome182
Effective interventions to address maternal and child malnutrition: an update of the evidence180
Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance172
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study158
Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study157
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group152
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease147
COVID-19 public health measures and respiratory syncytial virus143
Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children141
Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study137
Young people's mental health during the COVID-19 pandemic130
Delivering transformative action in paediatric pain: a Lancet Child & Adolescent Health Commission124
6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study123
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis122
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?116
Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study112
Respiratory syncytial virus: paying the immunity debt with interest111
Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database105
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial101
Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study91
Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people88
Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection84
The severity of COVID-19 in children on immunosuppressive medication81
Pandemic school closures: risks and opportunities80
COVID-19 in a 26-week preterm neonate79
Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation78
Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial78
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease an76
Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis76
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study74
SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study73
Prevalence and number of children living in institutional care: global, regional, and country estimates73
A machine-learning algorithm for neonatal seizure recognition: a multicentre, randomised, controlled trial71
Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys71
Septic shock presentation in adolescents with COVID-1970
Children's emergency presentations during the COVID-19 pandemic70
A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units70
Adolescent obesity and dietary decision making—a brain-health perspective69
The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis68
COVID-19 and eating disorders in young people67
Long COVID symptoms in SARS-CoV-2-positive children aged 0–14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study66
Renal dysfunction in hospitalised children with COVID-1964
Rates and time trends in the consumption of breastmilk, formula, and animal milk by children younger than 2 years from 2000 to 2019: analysis of 113 countries63
Multisystem inflammatory syndrome in children in South Africa63
0.053600788116455